AI in Medicine News ・ 💊 Drug discovery and clinical trials

AI drug discovery tools dominated early-stage pharma research after COVID-19, review finds

Bioengineer.org · 11/05 21:53 UTC

A systematic review of 57 studies finds that AI-enabled Pharma 4.0 tools after COVID-19 concentrated on early-stage drug discovery metrics. The review found limited evidence of clinical benefit.

Read the original (Bioengineer.org)

See it in the digest → ・ See this issue →